Yahoo EntertainmentKandi Burruss Is Tearful Over Not Being Able to Bring Blaze on the Girls' Trip
- Oops!Something went wrong.Please try again later.
Kenya Moore brought her daughter on the girls' trip, but what about everyone else?!
Kenya Moore brought her daughter on the girls' trip, but what about everyone else?!
If Daryl had to choose between his long-term friend, Maggie, and the man who killed her husband, Negan, Norman Reedus says he's #TeamMaggie.
Season five of "The Masked Singer" will premiere on March 10 - here's who you will see competing for the crown.
An unidentified doctor talks with a boy who holds a lollipop reward after participating in a measles vaccine research program in Upper Darby, Pennsylvania, in 1963. NASA/PhotoQuest/Getty ImagesNearly 50 million people in the U.S. had received at least one dose of the coronavirus vaccine by March 1, and millions of others have spent hours online trying to get an appointment. But soon, the demand could fall because of vaccine hesitancy. How is the government going to get people on board? From my research, I have found that an important part of a successful vaccine campaign is in the name. As a health communication scholar who studies the history of epidemics, I have been interested in the naming and public delivery of the COVID-19 government response. In many ways, this moment parallels crises of the past, as people in previous epidemics and pandemics also struggled to find ways to protect themselves against deadly disease. Dr. Anthony Fauci, the head of the National Institute of Allergy and Infectious Diseases, speaking about Zika in January 2016. Win McNamee/Getty Images Abandoning the ‘Operation Warp Speed’ name In the week leading up to the 2021 presidential inauguration, the Biden transition team announced that the White House’s national COVID-19 vaccine plan would no longer be called “Operation Warp Speed,” the name coined by Biden’s predecessor, Donald Trump. On Jan. 21, 2021, the Biden administration released its 200-page COVID-19 plan, “The National Strategy for the COVID-19 Response and Pandemic Preparedness.” The change in names not only broadened the focus to include additional safety measures to curb transmission during the distribution process. It also signified a profound shift in the administration’s approach and consideration of the pandemic itself. Dr. Anthony Fauci and other public health experts criticized the “Operation Warp Speed” name, arguing that it falsely conveyed a lack of scientific rigor and adherence to safety protocol in the vaccine approval process. In a May 15, 2020, press conference, Trump explained the campaign name, stating, “It’s called ‘Operation Warp Speed.’ That means big, and it means fast. A massive scientific, industrial and logistical endeavor unlike anything our country has seen since the Manhattan Project.” Fauci and others believed that the name “Operation Warp Speed” could have undermined public trust in any COVID-19 vaccine to be developed, feeding into theories and misconceptions of the anti-vaccine movement. It also marked a historical deviation in the identification of vaccine campaigns for the general public. The names we Americans use broadly today, inoculation and vaccination, emerged as the names for very specific immunization procedures against a specific disease, smallpox. Smallpox: A big controversy In the past, immunization terms stemmed from the induced immunological protection against smallpox. During the Boston smallpox epidemic of 1721, for example, Puritan minister Cotton Mather and Colonial physician Dr. Zabdiel Boylston introduced the practice of inoculation in hopes of protecting the town. Onesimus, an enslaved man who was in bondage to Mather, had told Mather of the practice and how he had been inoculated as a child in Africa. The practice involved intentionally infecting people with smallpox in hopes of reducing its severity. People fiercely discussed this controversial approach in public discourse, even spurring James Franklin, older brother of Benjamin, to create the New England Courant as an outlet to oppose its practice. Many articles in The Courant, Boston Gazette and the Boston News-Letter, along with pamphlets, argued for and against the practice of inoculation. This cemented the term in 18th-century vocabulary, along with its alternative name, “variolation.” This practice, and growing public familiarity with it, set the stage for acceptance of the first vaccine, which would change the course of disease. In 1798, English physician Dr. Edward Jenner proposed that inducing a mild cowpox infection could protect against smallpox – which he called a “vaccine,” from vaccinia, meaning cowpox. Millions of people already have been vaccinated. Michael Ciaglo/Getty Images Say its name Immunization campaigns for approved and established vaccines have often gone unnamed, simply listing the disease name, location and date, like the 1916 typhoid vaccine campaign in North Carolina’s Catawba County, northwest of Charlotte, North Carolina. Even sponsored vaccine programs have not necessarily taken on the name of the supporting corporation. In 1926, the Metropolitan Life Insurance Co. donated US$15,000 toward the eradication of diphtheria in New York. Despite this contribution, the campaign went unnamed. In the trial and development stage, vaccines were not typically named, even in the press. News articles referred to the “anti-disease” vaccine – that is, “anti-smallpox,” “anti-typhoid,” “anti-tetanus” – sometimes including the lead scientist’s last name, as with the Enders measles vaccine. For example, although polio vaccine trials in 1954 labeled the recruited child participants “polio pioneers,” the vaccine itself was called the “anti-polio” or Salk vaccine. Nicknaming vaccines can be a problem When vaccine campaigns have been named, catchy or abstract names can be problematic, especially in the experimental stages. The 1950s gamma globulin trials prompted confusion with the nickname “Operation Lollipop,” which referred to the “all-day sucker” given to children after the injection. Some people misunderstood, believing that scientists had delivered the actual polio virus in the candy to participants, prompting clarification that the name “had nothing to do with the experiment itself.” A Star Wars poster from 1977 encouraged immunization. Centers for Disease Control and Prevention More often, campaigns and slogans have been used in catch-up immunization drives after already widely distributed vaccines, as in the polio vaccine “Wellbee,” Utah’s 1967 “Muzzle Measles,” the 1977 Star Wars “Parents of Earth” message or the 1997 Dr. Seuss Immunization Awareness Campaign. These programs highlighted the importance of existing vaccines, rather than introducing new ones. As public health officials have noted, the title “Operation Warp Speed,” combined with the lack of a strategic COVID-19 response plan under the Trump administration, took away from the strict adherence to safety protocols that vaccine producers and the Food and Drug Administration have followed. In a Gallup Panel survey from Dec. 15, 2020, to Jan. 3, 2021, 65% of participants said they would get the vaccine, with divisions in age, race, education and party affiliation. The name “Operation Warp Speed” paired with coronavirus misinformation, much of it directly from Trump, likely contributed to the lack of trust in the vaccines before they were even developed. At least 75% to 80% of the population needs to become immunized – the number needed for herd immunity – to end of the pandemic, according to Fauci. Thus, I believe it will be important to develop a trustworthy campaign and a name that bolsters confidence. The Biden administration is not starting from scratch. I believe that the Biden administration’s adoption of a new direct name for its response plan is the first step toward pandemic recovery. Building confidence across various groups and communities will be critical for herd immunity to be achieved. The new campaign name, then, initiated what needs to be a straightforward, factual approach, integral to widespread COVID-19 immunization.This article is republished from The Conversation, a nonprofit news site dedicated to sharing ideas from academic experts. It was written by: Katherine A. Foss, Middle Tennessee State University. Read more:How does the Johnson & Johnson vaccine compare to other coronavirus vaccines? 4 questions answeredCan vaccinated people still spread the coronavirus? Katherine A. Foss does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
Three men and a woman pleaded not guilty on Tuesday to a charge of criminal damage over their alleged role in the toppling of a statue of 17th century slave trade magnate Edward Colston in Bristol in southwest England last year. The statue was pulled down and tossed into Bristol harbour during an anti-racism demonstration on June 7 that was part of a global wave of Black Lives Matter protests. The toppling of the statue led to other memorials of figures linked to the slave trade being taken down or their future being debated, triggering a backlash from government ministers who said this amounted to censoring history.
When the 'Punky Brewster' star embarked on a new documentary, she found that confronting her past, including surviving sexual assault, was the only way forward.
An Insider reporter struggled to book an appointment and had to wait in line for hours to get the first dose of the Moderna vaccine.
"Like, there are five people dead, two that took their own life on top of that, as a result of what you did," Kinzinger said of Hawley.
Paying ransoms to kidnappers is fuelling the mass abduction of students in northern Nigeria, analysts say.
‘Morning Joe’ hosts laugh at senator’s continued subservience to former president
Biden's White House has essentially leaned on the importance of the diplomatic relationship with Saudi Arabia in defense of its actions.
Some business and personal taxes “have to go up”, Lord Hague, the former Conservative leader and close ally of Rishi Sunak, the Chancellor, has warned. In a new article for The Telegraph, Lord Hague writes that people who oppose some form of tax rises in the current climate are buying into “dangerous illusions”. The intervention the day before Mr Sunak stands up to deliver his Budget will raise eyebrows, given the fierce debate about tax rises in the party and the pair’s close relationship. Mr Sunak took over Lord Hague’s seat of Richmond, Yorks, when the latter stepped down as a Tory MP in 2015. Both men will appear at the Budget event together on Friday. “It pains me to say, after spending much of my life arguing for lower taxes, that we have reached the point where at least some business and personal taxes have to go up,” Lord Hague writes. He adds: "Conservatives need to remember that for 200 years, from Pitt in 1797 to Thatcher and Cameron in our own day, keeping the country creditworthy has stood them in very good stead." The Chancellor has been mulling over a string of tax rises or raids for his Budget but has faced warnings from prominent Conservative backbenchers and even David Cameron. Such public support from a prominent Tory grandee as Lord Hague will only further speculation Mr Sunak is preparing to defy calls not to raise taxes, or at least indicate rises are coming soon. The Telegraph can reveal Mr Sunak will announce a £300 million funding boost to save summer sports such as cricket and tennis from the Covid-triggered cash squeeze. Tens of millions of pounds are expected to go to the England and Wales Cricket Board (ECB), allowing it to protect grassroots cricket and ease the return of fans into grounds. Lord Ian Botham, the former England cricket captain, told The Telegraph: “Everyone in the cricketing world will be delighted. It’s been a tough time for the sport.” Mr Sunak is also preparing to spend £408 million to help museums, theatres and galleries in England to reopen once coronavirus restrictions start to ease, it was reported on Monday night. The Chancellor will also announce a new scheme to help 130,000 small businesses expand by funding improvements in their digital operations and offering MBA-like business training. One part of the scheme, dubbed “Help to Grow”, will offer vouchers of up to £5,000 for businesses to buy new software to improve their online operations. Another will see 30,000 small company leaders offered training at some of the UK’s finest business schools and mentoring so they can improve their plans for growth. A Treasury source said the £520 million scheme is one of the “big bets” in the Budget and was inspired by Mr Sunak’s own experience of taking an MBA course at Stanford University in America. Boris Johnson said on Monday that he believed a "strong, jobs-led recovery" was coming, adding: “I think [it] could be much stronger than many of the pessimists have been saying over the last six months or so." Mr Sunak, in a video shared on Twitter, also offered notes of optimism amid frank warnings about the state of the economy, saying: “We have to believe there is light at the end of the tunnel now.”
Some believers think Trump will take power again on 4 March
The White House plans to withdraw Neera Tanden's nomination to head the Office of Management and Budget, a White House official said on Tuesday.
The comic legends told Jimmy Kimmel that Louie Anderson was cast in the classic 1980s comedy because he was one of three names given to them.
President Biden's failure to punish the Saudi crown prince defies justice and weakens the rule of law everywhere.
Rep. Matt Gaetz tells 'Tucker Carlson Tonight' Gen. Russel Honoré 'has already cast judgment' and 'needs to be removed.'
France and its Western allies plan to lodge a protest with the United Nations' nuclear watchdog to criticise Iran's decision to curb cooperation with the agency, the French foreign minister said on Tuesday. Iran said last month it was scaling back cooperation with the International Atomic Energy Agency, ending extra inspection and monitoring measures introduced by the 2015 nuclear deal, including the power given to the IAEA to carry out snap inspections at facilities not declared by Iran. "The nuclear tensions will lead us in the coming days to put forward a protest in the framework of the IAEA Board of Governors to regret this decision," Minister Jean-Yves Le Drian told a parliamentary hearing.
Ukrainian President Volodymyr Zelenskiy had a coronavirus vaccine shot during a visit to the frontline in the eastern Donbass region on Tuesday, hoping to reassure sceptics that the vaccine is safe and effective. Lagging behind the rest of Europe, Ukraine has only just started vaccinating its 41 million people after receiving its first batch of 500,000 Indian-made AstraZeneca shots last month, prioritising frontline healthcare workers and the military. Zelenskiy, whose government has blocked the use of Russia's Sputnik V vaccine, has urged European Union leaders to send vaccines to Ukraine and other countries on the periphery of the EU as a gesture of solidarity, and as a matter of "politics and geopolitics".
The de facto U.S. and Canadian embassies in Taiwan on Tuesday praised the quality of pineapples grown on the island, depicting photographs of their top diplomats in Taipei with the fruit after an import ban by China. China last week stopped the import of Taiwanese pineapples, citing "harmful creatures" it said could come with the fruit. Infuriated Taiwanese authorities called the ban a political move to further pressure the island, a charge that China denied.
Carl Court/GettyBy William G. Bain, Georgios D. Kitsios, and Tomeka L. SuberA year ago, when U.S. health authorities issued their first warning that COVID-19 would cause severe “disruption to everyday life,” doctors had no effective treatments to offer beyond supportive care.There is still no cure, but thanks to an unprecedented global research effort, several treatments are helping patients survive COVID-19 and stay out of the hospital altogether.COVID-19 treatments target two broad problems: the coronavirus’s ability to spread through the body, and the damage caused by the body’s immune system response. When the virus enters the body, it takes over cells and uses them to replicate itself. In response, the body sends inflammatory signals and immune cells to fight the virus. In some patients, that inflammatory response can continue even after the virus is under control, leading to damage in the lungs and other organs.The best tool is prevention, including using face masks and vaccines. Vaccines train the immune system to fight off attackers. With less risk of an uncontrolled infection, they can cut the risk of death from COVID-19 to near zero. But vaccine supplies are limited, even with a third vaccine now authorized for U.S. use, so treatments for infected patients remain crucial.This Drug Is a Staple of COVID Treatment. Should It Be?As doctors who work with COVID-19 patients, we have been following the drug trials and success stories. Here are six treatments commonly used today for COVID-19. As you’ll see, timing matters.Keeping you out of the hospitalTwo promising types of treatments involve injecting antiviral antibodies into high-risk COVID-19 patients before the person becomes severely ill.Our bodies naturally create antibodies to recognize foreign invaders and help fight them off. But natural antibody production takes several days, and SARS-CoV-2—the coronavirus that causes COVID-19—replicates fast. Studies show that injecting patients with antibodies soon after symptoms begin can help protect patients against serious infection.Monoclonal antibodies: These lab-engineered antibodies can bind to SARS-CoV-2 and prevent the virus from entering cells and infecting them. They include Bamlanivimab and the combined therapy casirivimab/imdevimab developed by Regeneron. The U.S. Food and Drug Administration granted emergency use authorization for these therapies because they have been found to protect high-risk patients from hospitalization and death. Once patients are sick enough to need hospitalization, however, studies haven’t found a proven benefit from them.Convalescent plasma: Another way to deliver antibodies involves blood drawn from patients who have recovered from COVID-19. Convalescent plasma is primarily given in research settings because the clinical evidence so far is mixed. Some trials show benefits early in the disease. Other studies have not shown any benefit in hospitalized patients.There may be a role for convalescent plasma as a supplemental therapy for some patients because of the growing threat of mutated SARS-CoV-2 variants, which may evade monoclonal antibody therapy. However, careful research is necessary.If you are hospitalizedOnce patients become so sick that they have to be hospitalized, treatments change.Most hospitalized patients have difficulty breathing and low oxygen levels. Low oxygen occurs when the virus and corresponding immune response injure the lungs, resulting in swelling in lung air sacs that restricts the amount of oxygen getting into the blood. Patients hospitalized with COVID-19 usually need supplemental medical oxygen to help them breathe. Doctors frequently treat patients on oxygen with the antiviral agent remdesivir and anti-inflammatory corticosteroids.Remdesivir: Remdesivir, originally designed to treat hepatitis C, stops the coronavirus from replicating itself by interfering with its genetic building blocks. It has been shown to shorten the length of hospital stays, and doctors may prescribe it to patients on oxygen shortly after arrival in the hospital.Chris Christie Says He’s Out of the Hospital After Week-Long Stay for COVID-19Corticosteroids: Steroids calm the body’s immune response and have been used for decades to treat inflammatory disorders. They are also widely available, cheap and well-studied medications, so they were among the first therapies to enter clinical trials for COVID-19. Several studies have shown that low-dose steroids reduce deaths in hospitalized patients who are on oxygen, including the sickest patients in the intensive care unit, or ICU. Following the findings of the landmark RECOVERY and REMAP-CAP COVID-19 studies, steroids are now the standard of care for patients hospitalized with COVID-19 who are treated with oxygen.Blood thinners: Inflammation during COVID-19 and other viral infections can also increase the risk of blood clots, which can cause heart attacks, strokes and dangerous clots in the lungs. Many patients with COVID-19 are given the blood thinners heparin or enoxaparin to prevent clots before they occur. Early data from a large trial of COVID-19 patients suggests that hospitalized patients benefit from higher doses of blood thinners.Some patients with COVID-19 become so sick that they need an ICU for high levels of oxygen support or a ventilator to help them breathe. There are several therapies available for ICU patients, but ICU patients have not been found to benefit from high doses of blood thinners.Treating the sickest patientsICU patients with COVID-19 are more likely to survive if they receive steroids, studies have found. However, low-dose steroids alone may not be enough to curb excessive inflammation.Tocilizumab: Tocilizumab is a lab-generated antibody that blocks the interleukin-6 pathway, which can cause inflammation during COVID-19 and other diseases. New results from the REMAP-CAP trial that have not yet been peer-reviewed suggest that a single dose of tocilizumab given within one to two days after being placed on respiratory support reduced the risk of death in patients already receiving low-dose steroids. Tocilizumab has also been shown to benefit patients with high levels of inflammation in early results from another trial.These innovative therapies can help, but careful supportive care in the ICU is also crucial. Decades of extensive research have defined core management principles for helping patients with severe lung infections who need ventilators. These include avoiding underinflation and overinflation of the lung by the ventilator, treating pain and anxiety with low levels of sedative medications, and periodically placing certain patients with low oxygen levels on their belly, among many other interventions. The same key principles likely apply to patients with COVID-19 to help them survive and recover from a critical illness that can last weeks or months.Medical progress since the start of the pandemic has been awe-inspiring. Doctors now have vaccines, antiviral antibodies for high-risk outpatients and several treatments for hospitalized patients. Continued research will be crucial to improve our ability to fight a disease that has already claimed more than 2.5 million lives worldwide.William G. Bain, Georgios D. Kitsios, and Tomeka L. Suber are assistant professors of medicine at the University of PittsburghRead more at The Daily Beast.Get our top stories in your inbox every day. Sign up now!Daily Beast Membership: Beast Inside goes deeper on the stories that matter to you. Learn more.